TR201007652A2 - Sinerjik etki. - Google Patents
Sinerjik etki.Info
- Publication number
- TR201007652A2 TR201007652A2 TR2010/07652A TR201007652A TR201007652A2 TR 201007652 A2 TR201007652 A2 TR 201007652A2 TR 2010/07652 A TR2010/07652 A TR 2010/07652A TR 201007652 A TR201007652 A TR 201007652A TR 201007652 A2 TR201007652 A2 TR 201007652A2
- Authority
- TR
- Turkey
- Prior art keywords
- synergistic effect
- acetylcysteine
- sedative
- generation
- invention includes
- Prior art date
Links
- 230000002195 synergetic effect Effects 0.000 title 1
- PWKSKIMOESPYIA-BYPYZUCNSA-N L-N-acetyl-Cysteine Chemical compound CC(=O)N[C@@H](CS)C(O)=O PWKSKIMOESPYIA-BYPYZUCNSA-N 0.000 abstract 1
- 229960004308 acetylcysteine Drugs 0.000 abstract 1
- 239000003172 expectorant agent Substances 0.000 abstract 1
- 239000000938 histamine H1 antagonist Substances 0.000 abstract 1
- 229940066491 mucolytics Drugs 0.000 abstract 1
- 239000000932 sedative agent Substances 0.000 abstract 1
- 230000001624 sedative effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/4545—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| TR2010/07652A TR201007652A2 (tr) | 2010-09-20 | 2010-09-20 | Sinerjik etki. |
| PCT/TR2011/000213 WO2012039691A2 (en) | 2010-09-20 | 2011-09-20 | Synergic effect |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| TR2010/07652A TR201007652A2 (tr) | 2010-09-20 | 2010-09-20 | Sinerjik etki. |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TR201007652A2 true TR201007652A2 (tr) | 2012-04-24 |
Family
ID=45034153
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TR2010/07652A TR201007652A2 (tr) | 2010-09-20 | 2010-09-20 | Sinerjik etki. |
Country Status (2)
| Country | Link |
|---|---|
| TR (1) | TR201007652A2 (xx) |
| WO (1) | WO2012039691A2 (xx) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106109422A (zh) * | 2016-07-28 | 2016-11-16 | 北京万全德众医药生物技术有限公司 | 盐酸左西替利嗪泡腾颗粒及其制备方法 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3184505A (en) | 1962-06-18 | 1965-05-18 | Mead Johnson & Co | Process for the n-monoacylation of cysteine |
| FI75816C (fi) | 1981-02-06 | 1988-08-08 | Ucb Sa | Foerfarande foer framstaellning av terapeutiskt aktiv 2-/4-(difenylmetyl)-1-piperazinyl/-aettiksyror eller dess amid. |
| WO1985003707A1 (en) | 1984-02-15 | 1985-08-29 | Schering Corporation | 8-CHLORO-6,11-DIHYDRO-11-(4-PIPERIDYLIDENE)-5H-BENZO AD5,6 BDCYCLOHEPTA AD1,2-b BDPYRIDINE AND ITS SALTS, PROCESSES FOR THE PRODUCTION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING THESE COMPOUNDS |
| GB8827391D0 (en) | 1988-11-23 | 1988-12-29 | Ucb Sa | Process for preparation of 2-(2-(4-((4-chlorophenyl)phenylmethyl)-1-pipera-zinyl)ethoxy)-acetic acid & its dihydrochloride |
| ATE170749T1 (de) | 1992-09-24 | 1998-09-15 | Sepracor Inc | Verwendung von (-) cetirizin zur behandlung allergischer rhinitis und und asthma |
| WO2001085148A2 (en) * | 2000-05-05 | 2001-11-15 | Aventis Pharmaceuticals Inc. | Packaging regimen of pseudoephedrine hydrochloride and fexofenadine hydrocloride |
| US7955620B2 (en) * | 2003-12-23 | 2011-06-07 | Sun Pharmaceutical Industries Limited | Stable oral composition |
| US20080139654A1 (en) * | 2006-12-09 | 2008-06-12 | Eric Mott Soderling | Acetaminophen compositions having minimized side effects including reduced hepatotoxicity |
-
2010
- 2010-09-20 TR TR2010/07652A patent/TR201007652A2/xx unknown
-
2011
- 2011-09-20 WO PCT/TR2011/000213 patent/WO2012039691A2/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| WO2012039691A3 (en) | 2012-05-18 |
| WO2012039691A2 (en) | 2012-03-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1121390T1 (el) | Πυρρολοβενζοδιαζεπινες και συζευγματα αυτων | |
| PH12013500065A1 (en) | Deuterated n-ethyl-n-phenyl-1,2-dihydro-4-hydroxy-5-chloro-1-methyl-2-oxoquinoline-3-carboxamide, salts and uses thereof | |
| CL2012002979A1 (es) | Derivados de n3-sustituido-n1-sulfonil-5-fluorpirimidinona. | |
| BR112013031361A2 (pt) | galactomanana cationicamente e anfifilicamente modificada, e, composição | |
| GB2506783A (en) | Enabling a computing device to utilize another computing device | |
| TR201907828T4 (tr) | Geni̇ş spektrumlu bi̇r anti̇-mi̇krobi̇yel ajan | |
| BR112015019647A2 (pt) | criação de perfil de caminho com uso de combinação de hardware e software. | |
| IT1399905B1 (it) | Struttura tessile laminare, particolarmente idonea per componenti acustici. | |
| DK2568854T3 (da) | Sædeindretning | |
| EP3011430A4 (en) | Unifying application log messages using runtime instrumentation | |
| UY4223Q (es) | Banco | |
| TR201904120T4 (tr) | Konnektör parçası. | |
| CL2009001973S1 (es) | Mostrador. | |
| EP2710024A4 (en) | OSW-1 ANALOGA AND CONJUGATES AND ITS USE | |
| FR2964411B1 (fr) | Aube de turboreacteur, notamment une aube de redresseur, et turboreacteur recevant de telles aubes | |
| UY4243Q (es) | Banco | |
| TR200903176A1 (tr) | Çoklu blister. | |
| TR201007652A2 (tr) | Sinerjik etki. | |
| IT1399443B1 (it) | Indumento intimo. | |
| IT1399581B1 (it) | Dispositivo per la protezione di parti del corpo di un individuo, in particolare per la protezione della schiena. | |
| TR201900608T4 (tr) | Bir hava hazırlama cihazına sahip olan davlumbaz cihazı. | |
| TR201005220U (tr) | Kabloların sevkiyatı için kullanılan makaralarda yenilik. | |
| TN2010000567A1 (fr) | المحطة الكهرمائية الشمسية | |
| TN2010000017A1 (fr) | مستحضر تجميلي دوائي | |
| ES1074160Y (es) | Bandeja posterior enrollable con doble apertura para automovil. |